Brickell Biotech Inc (NASDAQ:BBI)

1.15
Delayed Data
As of May 29
 +0.05 / +4.55%
Today’s Change
0.99
Today|||52-Week Range
8.40
-23.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues21.0M14.5M13.8M1.6M
 
 
 
 
 
Cost of Goods Sold10.0M5.2M5.7M501.0K
 
 
 
 
 
Depreciation And Amortization1.2M1.1M793.0K200.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.8M8.2M7.3M921.0K
 
 
 
 
 
General Expenses19.2M17.4M20.7M17.3M
 
 
 
 
 
Research And Development10.9M10.4M14.4M11.1M
 
 
 
 
 
Total Operating Expenses30.4M23.7M27.2M18.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.4M-9.2M-13.4M-16.4M
 
 
 
 
 
Extraordinary Charge0.000.000.00-3.3M
 
 
Other Expenses166.0K0.000.002.3M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.2M-9.0M-13.0M-16.3M
 
 
 
 
 
Net Income-9.2M-9.0M-13.0M-16.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.2M10.0M12.9M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted9.2M10.0M12.9M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$0.90-$1.01-$0.74
 
 
 
 
 
EPS Diluted-$1.00-$0.90-$1.01-$0.74